Company profile: Icagen
1.1 - Company Overview
Company description
- Provider of ion channel-focused drug discovery platforms and services, including the Ion Channel Technology combining novel reagent generation, advanced biophysical analysis, and in silico tools; discovery-to-lead optimization services; and partnering with pharma/biotech to advance orally administered small-molecule therapeutics in neuroscience and chronic kidney disease.
Products and services
- Drug Discovery and Development Services: End-to-end services focused on ion channels and transporters, spanning screening to lead optimization to address unmet needs in neuroscience and chronic kidney disease therapeutic programs
- Icagen Ion Channel Technology: Integrated platform advancing ion channel and transporter discovery by combining novel reagent generation, advanced biophysical analysis, and in silico tools for small molecule target modulation
- Partnering for Drug Discovery: Assay-driven collaborations with pharmaceutical and biotech partners to advance ion channel therapeutic programs, leveraging extensive experience and proprietary assays to accelerate discovery and development
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Icagen
Presidio Medical
HQ: United States
Website
- Description: Provider of a transformational neuromodulation platform and ULF Neuromodulation Therapy, which uses ultra low frequency current waveforms to inhibit pain signals; shown effective in clinical trials for chronic pain without causing paresthesia, enabling remedies for disorders affecting neuronal activity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Presidio Medical company profile →
Legacy Packaging
HQ: United States
Website
- Description: Provider of pharmaceutical packaging services including bottle filling (30cc–1500cc), blister packaging (thermoform and coldform), and unit-of-use bottling under its own or client NDC codes with rebate management. Offers Ecoslide compliance packaging (senior-friendly, child-resistant), secondary packaging (cartoning, clamshell/blistershell filling, display assembly, inspection), and inline/offline serialization solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Legacy Packaging company profile →
Resolian
HQ: United States
Website
- Description: Provider of multinational bioanalytical CRO services focused on medication metabolism and pharmacokinetics for small and big compounds.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Resolian company profile →
TD2
HQ: United States
Website
- Description: Provider of oncology-focused contract research services, offering data-driven clinical study management for Phase I–III trials; preclinical tools with 400+ cancer models to maximize data value and predict patient response; regulatory support (IND readiness, development, filings, FDA interactions); PK/ADME assays; and CDX models including NCI-H1963 (lung) and CCRF-CEM (T-ALL) to accelerate translational oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TD2 company profile →
Paragon Bioservices
HQ: United States
Website
- Description: Provider of contract development and manufacturing services for complex biopharmaceuticals, including AAV, oncolytic viruses, and next-generation vaccines. An industry-leading, private-equity backed CDMO focused on developing and manufacturing cutting-edge, transformative biopharmaceuticals and building strong client partnerships with the world's best biotech and pharma companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Paragon Bioservices company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Icagen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Icagen
2.2 - Growth funds investing in similar companies to Icagen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Icagen
4.2 - Public trading comparable groups for Icagen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →